K&L Gates Advises Luye Pharma Group Ltd. on European Market Entry
Frankfurt. Global law firm K&L Gates LLP has advised Luye Pharma Group Ltd. in connection with its market entry into Europe. Through a bidding process initiated by Avista Capital Partners and Nordic Capital, Luye succeeded in acquiring Acino’s transdermal drug delivery systems consisting of patches and biodegradable subcutaneous implants. The parties agreed that a carve-out of other business sectors of Acino shall be consummated prior to the closing of the transaction.
Listed on the Hong Kong Stock Exchange, Luye Pharma Group Ltd. develops and manufactures medicinal products. K&L Gates was chosen for the matter because of the seamless cooperation of its Chinese and German practice groups as well as its specific knowledge in the pharmaceutical industry sector.
The K&L Gates team that advised Luye on the deal included partners Claudius Paul (Lead, Corporate/M&A), Volker Gattringer (China Group, Corporate/M&A), and Dr. Mathias Schulze Steinen (Corporate/M&A), all Frankfurt; Frank Voon (Corporate/M&A, Beijing); Dr. Thorsten Vormann (IP Litigation, Frankfurt); Dr. Friederike Gräfin von Brühl (TMT, Berlin); Nicolas Roggel (Employment Law, Berlin); Rainer Schmitt (Tax, Frankfurt); and Dr. Annette Mutschler-Siebert (Competition Law, Berlin), as well as associates Tom Pagels and Dr. Arthur von Gruenewaldt (both Corporate/M&A, Frankfurt); Andreas Menge (Corporate/M&A, Berlin); Dr. Thomas Nietsch (TMT, Berlin); Dr. Isabel Kainer-Pfuhl and Marc-Ruben Hagedorn (both IP Litigation, Frankfurt); Nils Neumann (Employment Law, Berlin); and Marion Baumann (Competition Law, Berlin); and Yiqing Huang (China Group, Corporate/M&A), a PRC-qualified lawyer in Frankfurt.
K&L Gates comprises approximately 2,000 lawyers globally who practice in fully integrated offices located on five continents. The firm represents leading multinational corporations, growth and middle-market companies, capital markets participants and entrepreneurs in every major industry group as well as public sector entities, educational institutions, philanthropic organizations and individuals.